Skip to content
Altius – Lifestyle
Author:
Biovica International
New Meta-Analysis Strengthens Clinical Evidence for DiviTum TKa in Metastatic Breast Cancer
September 17, 2026
Announcement from the Annual General Meeting in Biovica International AB
September 17, 2026
Q1 Report – Focused Execution Driving Growth
September 10, 2026
Notice of Extra General Meeting in Biovica International AB
September 10, 2026
Biovica Resolves on a Fully Guaranteed Rights Issue of SEK 29.2 Million
September 10, 2026
New Publication Broadens the Potential of DiviTum TKa in Immuno-Oncology
August 25, 2026
Biovica Signs Laboratory Services Agreement with Leading U.S. Cancer Center
August 6, 2026
New Publication Strengthens the Case for DiviTum TKa in Early Treatment Assessment
August 4, 2026
Biovica Receives First Work Order Under Expanded Master Services Agreement with Leading Global Pharmaceutical Customer
July 20, 2026
Biovica Expands Japanese Patent Protection in Immuno-Oncology
July 16, 2026
1
2
3
Next Page
→